KNSA
Kiniksa Pharmaceuticals International, plcCompany with tickers: KNSA
CIK
1730430
Shares Outstanding
45,900,637
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Tax | 10,313 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Other | 109,795 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Award | 120,150 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Other | 51,794 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Convert | 21,327 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Award | 30,050 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Award | 60,100 |
| 2026-04-01 | Patel Sanj K | Director, CHAIRMAN & CEO | Convert | 6,481 |
| 2026-04-01 | Tessari Eben | CHIEF STRATEGY OFFICER | Award | 8,300 |
| 2026-04-01 | Tessari Eben | CHIEF STRATEGY OFFICER | Award | 16,600 |
| 2026-04-01 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 5,975 |
| 2026-04-01 | Tessari Eben | CHIEF STRATEGY OFFICER | Tax | 1,756 |
| 2026-04-01 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 1,773 |
| 2026-04-01 | Tessari Eben | CHIEF STRATEGY OFFICER | Award | 33,200 |
| 2026-04-01 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Award | 31,150 |
| 2026-04-01 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 5,187 |
| 2026-04-01 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Award | 7,800 |
| 2026-04-01 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Tax | 2,510 |
| 2026-04-01 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 1,750 |
| 2026-04-01 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Award | 15,600 |
| 2026-04-01 | Paolini John F. | CHIEF MEDICAL OFFICER | Award | 26,750 |
| 2026-04-01 | Paolini John F. | CHIEF MEDICAL OFFICER | Convert | 5,831 |
| 2026-04-01 | Paolini John F. | CHIEF MEDICAL OFFICER | Award | 13,400 |
| 2026-04-01 | Paolini John F. | CHIEF MEDICAL OFFICER | Award | 6,700 |
| 2026-04-01 | Paolini John F. | CHIEF MEDICAL OFFICER | Convert | 1,624 |
| 2026-04-01 | Paolini John F. | CHIEF MEDICAL OFFICER | Tax | 2,821 |
| 2026-04-01 | Moat Ross | CHIEF OPERATING OFFICER | Award | 9,250 |
| 2026-04-01 | Moat Ross | CHIEF OPERATING OFFICER | Convert | 1,611 |
| 2026-04-01 | Moat Ross | CHIEF OPERATING OFFICER | Award | 36,950 |
| 2026-04-01 | Moat Ross | CHIEF OPERATING OFFICER | Award | 18,500 |
| 2026-04-01 | Moat Ross | CHIEF OPERATING OFFICER | Convert | 5,808 |
| 2026-04-01 | Moat Ross | CHIEF OPERATING OFFICER | Tax | 1,706 |
| 2026-04-01 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Award | 7,300 |
| 2026-04-01 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Convert | 2,558 |
| 2026-04-01 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Tax | 3,205 |
| 2026-04-01 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Convert | 7,564 |
| 2026-04-01 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Award | 14,600 |
| 2026-04-01 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Award | 3,650 |
| 2026-03-09 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 2,036 |
| 2026-03-09 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 17,981 |
| 2026-03-09 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 2,036 |
| 2026-03-02 | Paolini John F. | CHIEF MEDICAL OFFICER | Convert | 40,000 |
| 2026-03-02 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 12,063 |
| 2026-03-02 | Paolini John F. | CHIEF MEDICAL OFFICER | Convert | 40,000 |
| 2026-02-12 | Quart Barry D | Director | Sell | 2,690 |
| 2026-02-12 | Quart Barry D | Director | Convert | 2,690 |
| 2026-02-12 | Quart Barry D | Director | Convert | 2,690 |
| 2026-02-10 | Quart Barry D | Director | Convert | 110 |
| 2026-02-10 | Quart Barry D | Director | Sell | 110 |
| 2026-02-10 | Quart Barry D | Director | Convert | 110 |
| 2026-02-09 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 9,114 |
| 2026-02-09 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 8,374 |
| 2026-02-09 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 8,374 |
| 2026-02-04 | Quart Barry D | Director | Convert | 2,602 |
| 2026-02-04 | Quart Barry D | Director | Sell | 2,602 |
| 2026-02-04 | Quart Barry D | Director | Convert | 2,602 |
| 2026-02-03 | Quart Barry D | Director | Sell | 12,528 |
| 2026-02-03 | Quart Barry D | Director | Convert | 12,528 |
| 2026-02-03 | Quart Barry D | Director | Convert | 12,528 |
| 2026-02-02 | Quart Barry D | Director | Sell | 830 |
| 2026-02-02 | Quart Barry D | Director | Convert | 830 |
| 2026-02-02 | Quart Barry D | Director | Convert | 830 |
| 2026-02-01 | Levy Richard S | Director | Convert | 683 |
| 2026-02-01 | Levy Richard S | Director | Convert | 683 |
| 2026-02-01 | Levy Richard S | Director | Award | 683 |
| 2026-01-15 | Tessari Eben | CHIEF STRATEGY OFFICER | Award | 365 |
| 2026-01-15 | Moat Ross | CHIEF OPERATING OFFICER | Award | 879 |
| 2026-01-15 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Award | 372 |
| 2026-01-08 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 12,000 |
| 2025-12-15 | Quart Barry D | Director | Convert | 20,129 |
| 2025-12-15 | Quart Barry D | Director | Convert | 20,129 |
| 2025-12-15 | Quart Barry D | Director | Sell | 20,129 |
| 2025-12-15 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 6,000 |
| 2025-12-15 | Tessari Eben | CHIEF STRATEGY OFFICER | Sell | 12,048 |
| 2025-12-15 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 6,000 |
| 2025-12-08 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 16,164 |
| 2025-12-08 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 42,841 |
| 2025-12-08 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 16,164 |
| 2025-11-26 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 200 |
| 2025-11-26 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 200 |
| 2025-11-26 | Tessari Eben | CHIEF STRATEGY OFFICER | Sell | 200 |
| 2025-11-17 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 6,500 |
| 2025-11-17 | Tessari Eben | CHIEF STRATEGY OFFICER | Sell | 645 |
| 2025-11-17 | Tessari Eben | CHIEF STRATEGY OFFICER | Convert | 6,500 |
| 2025-11-13 | Patel Sanj K | Director, CHAIRMAN & CEO | Gift | 60,000 |
| 2025-11-12 | Patel Sanj K | Director, CHAIRMAN & CEO | Gift | 111,794 |
| 2025-11-12 | Patel Sanj K | Director, CHAIRMAN & CEO | Other | 109,795 |
| 2025-11-12 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 19,900 |
| 2025-11-12 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 19,900 |
| 2025-11-12 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 19,900 |
| 2025-10-31 | Paolini John F. | CHIEF MEDICAL OFFICER | Convert | 36,542 |
| 2025-10-31 | Paolini John F. | CHIEF MEDICAL OFFICER | Convert | 36,542 |
| 2025-10-31 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 82,542 |
| 2025-10-28 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 100 |
| 2025-10-28 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 100 |
| 2025-10-28 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Convert | 100 |
| 2025-10-22 | Patel Sanj K | Director, CHAIRMAN & CEO | Sell | 97,390 |
| 2025-10-22 | Patel Sanj K | Director, CHAIRMAN & CEO | Convert | 97,390 |
| 2025-10-22 | Patel Sanj K | Director, CHAIRMAN & CEO | Convert | 97,390 |
| 2025-10-21 | Patel Sanj K | Director, CHAIRMAN & CEO | Sell | 39,331 |